Somavert Alternatives Compared
| Somavert Remove Somavert from your drug comparison | Sandostatin LAR Depot Remove Sandostatin LAR Depot from your drug comparison | Somatuline Depot Remove Somatuline Depot from your drug comparison |
|---|
| Somavert pegvisomant Remove Somavert from your drug comparison | Sandostatin LAR Depot octreotide Remove Sandostatin LAR Depot from your drug comparison | Somatuline Depot lanreotide Remove Somatuline Depot from your drug comparison | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Acromegaly. Somavert may also be used for purposes not listed in this medication guide. |
Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Sandostatin LAR Depot may also be used for purposes not listed in this medication guide. |
Prescribed for Neuroendocrine Carcinoma, Carcinoid Syndrome, Acromegaly. Somatuline Depot may also be used for purposes not listed in this medication guide. |
||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
|
See the full Somavert side effects document. |
See the full Sandostatin LAR Depot side effects document. |
Common side effects include: diarrhea. See the full Somatuline Depot side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all Somavert prices |
View all Sandostatin LAR Depot prices and generic prices |
View all Somatuline Depot prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
|
No |
No |
|||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
|
N/A |
Other octreotide brands include: Bynfezia Pen, Mycapssa, Sandostatin |
N/A |
||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
|
144 hours |
1.5 hours |
720 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
|
A total of 71 drugs are known to interact with Somavert:
|
A total of 139 drugs are known to interact with Sandostatin LAR Depot:
|
A total of 137 drugs are known to interact with Somatuline Depot:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
|
March 25, 2003 |
N/A |
N/A |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.